| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing aspirin and caffeine and dextropropoxyphene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin and butalbital and caffeine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only aspirin and caffeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only buffered aspirin and caffeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only butalbital and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only aspirin and caffeine and dextropropoxyphene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only aspirin and caffeine and orphenadrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only aspirin and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only aspirin and caffeine and cinnamedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ammonium chloride and caffeine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only caffeine and codeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only caffeine and dihydrocodeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only caffeine and ergotamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine and glucose only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only caffeine and isometheptene and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine and paracetamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only aspirin and butalbital and caffeine and codeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine and paracetamol and salicylamide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only caffeine and sodium benzoate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aspirin and caffeine and dihydrocodeine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only butalbital and caffeine and codeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine and codeine and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine and dihydrocodeine and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only caffeine and ergotamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only caffeine and ergotamine in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only caffeine and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only caffeine and sodium benzoate in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only caffeine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only aspirin and butalbital and caffeine and codeine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin and butalbital and caffeine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only aspirin and caffeine and dextropropoxyphene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only aspirin and caffeine and dihydrocodeine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only aspirin and caffeine and orphenadrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only aspirin and caffeine and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Butalbital and caffeine and codeine and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only butalbital and caffeine and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely caffeine 650 microgram/1 milliliter and paracetamol 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely caffeine 650 microgram/1 milliliter and paracetamol 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing caffeine and isometheptene and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only caffeine and isometheptene and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| The known quantity of intake in one day of caffeine from all sources. |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
6 |
| Estimated quantity of intake of caffeine in 24 hours |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
6 |
| Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine 25 mg and paracetamol 450 mg oral tablet |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine 15 mg and codeine phosphate 15 mg and paracetamol 300 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine 15 mg and codeine phosphate 15 mg and paracetamol 300 mg oral tablet |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine-induced anxiety disorder |
Causative agent (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Estimated quantity of intake of caffeine in 24 hours |
Process acts on |
False |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| The known quantity of intake in one day of caffeine from all sources. |
Process acts on |
False |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Caffeine intake |
Process acts on |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Headache due to caffeine withdrawal syndrome |
Causative agent (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine anhydrous |
Is modification of (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Caffeine 32 mg and paracetamol 500 mg oral capsule |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine 32 mg and paracetamol 500 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine 25 mg and guaifenesin 100 mg and paracetamol 500 mg oral capsule |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine 25 mg and guaifenesin 100 mg and paracetamol 500 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine- and guaifenesin- and paracetamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine and guaifenesin and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine 30 mg and codeine phosphate 8 mg and paracetamol 500 mg oral capsule |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Caffeine 30 mg and codeine phosphate 8 mg and paracetamol 500 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 325 mg and caffeine 15 mg oral tablet |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin 325 mg and caffeine 15 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only aspirin and caffeine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin- and caffeine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Brompheniramine maleate 3 mg and caffeine 30 mg and paracetamol 325 mg oral tablet |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Brompheniramine maleate 3 mg and caffeine 30 mg and paracetamol 325 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Brompheniramine- and caffeine- and paracetamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only brompheniramine and caffeine and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only brompheniramine and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing brompheniramine and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely caffeine 30 milligram and codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely caffeine 30 milligram and codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Episode of harmful use of caffeine (disorder) |
Causative agent (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Disorder characterized by the pattern and consequences of caffeine use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user. |
Causative agent (attribute) |
True |
Caffeine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]